Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,674
archived clinical trials in
Skin Cancer

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Oncology Hematology Associates of Central Illinois, PC - Ottawa
mi
from
Ottawa, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Oncology Hematology Associates of Central Illinois, PC - Ottawa
mi
from
Ottawa, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Proctor Hospital
mi
from
Peoria, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Proctor Hospital
mi
from
Peoria, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
OSF St. Francis Medical Center
mi
from
Peoria, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Illinois Valley Community Hospital
mi
from
Peru, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Illinois Valley Community Hospital
mi
from
Peru, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Perry Memorial Hospital
mi
from
Princeton, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Perry Memorial Hospital
mi
from
Princeton, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Margaret's Hospital
mi
from
Spring Valley, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Margaret's Hospital
mi
from
Spring Valley, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Carle Cancer Center at Carle Foundation Hospital
mi
from
Urbana, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Carle Cancer Center at Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Elkhart General Hospital
mi
from
Elkhart, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Elkhart General Hospital
mi
from
Elkhart, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Howard Community Hospital
mi
from
Kokomo, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Howard Community Hospital
mi
from
Kokomo, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Saint Anthony Memorial Health Centers
mi
from
Michigan City, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Saint Anthony Memorial Health Centers
mi
from
Michigan City, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Memorial Hospital of South Bend
mi
from
South Bend, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Saint Joseph Regional Medical Center
mi
from
South Bend, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Saint Joseph Regional Medical Center
mi
from
South Bend, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
South Bend Clinic
mi
from
South Bend, IN
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
South Bend Clinic
mi
from
South Bend, IN
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
McFarland Clinic, PC
mi
from
Ames, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cedar Rapids Oncology Associates
mi
from
Cedar Rapids, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cedar Rapids Oncology Associates
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mercy Capitol Hospital
mi
from
Des Moines, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mercy Capitol Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mercy Cancer Center at Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mercy Cancer Center at Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
McCreery Cancer Center at Ottumwa Regional
mi
from
Ottumwa, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
McCreery Cancer Center at Ottumwa Regional
mi
from
Ottumwa, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Southwest Medical Center
mi
from
Liberal, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Southwest Medical Center
mi
from
Liberal, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Associates in Womens Health, PA - North Review
mi
from
Wichita, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Associates in Womens Health, PA - North Review
mi
from
Wichita, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KA
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials